Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing | Journal of Medical Genetics

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Citation Tools

Biochemical genetics

Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Goossens R, van den Boogaard ML, Lemmers RJLF, et al

Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing

Journal of Medical Genetics 2019;56:828-837.